» Articles » PMID: 15726219

Herbal Treatment for Renal Diseases

Overview
Specialty General Medicine
Date 2005 Feb 24
PMID 15726219
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Renal fibrosis is a common consequence of chronic kidney diseases (CKD). Standard therapy to prevent progression of CKD in western medicine includes dietary protein restriction, blood pressure control, angiotensin-converting enzyme inhibition and angiotensin receptor blockade. However, little is known about the renoprotective effects of Chinese herbal medicine. Cumulative evidence suggests that some Chinese herbal medicines, including Astragalus and a mixture of Astragalus plus Angelica, Ligusticum, Triptolide and Rhubarb, have a beneficial role in slowing the progression of CKD. This effect is multi-functional and multi-targeted, and is often associated with a reduction in proteinuria and the amelioration of dyslipidaemia, but not with changes in systemic blood pressure. These mechanisms include anti-inflammation and inhibition of TGF-b overproduction. On the other hand, some Chinese herbal medicines may be hazardous to patients with renal diseases. In this review, we discuss recent advances in the research of some Chinese herbs for pharmacological intervention of progressive renal diseases and kidney-related injuries.

Citing Articles

Therapeutic effects of Kangxian Yanshen formula on patients with chronic kidney disease stages 3-4: a retrospective cohort study.

Chu A, Wei W, Liu N, Zhang F, Zhang X, Li X Front Med (Lausanne). 2024; 11:1450561.

PMID: 39380733 PMC: 11458470. DOI: 10.3389/fmed.2024.1450561.


Saffron ( L.) and Its By-Products: Healthy Effects in Internal Medicine.

Marrone G, Urciuoli S, Di Lauro M, Cornali K, Montalto G, Masci C Nutrients. 2024; 16(14).

PMID: 39064764 PMC: 11279474. DOI: 10.3390/nu16142319.


Preventive Action of Beta-Carotene against the Indoxyl Sulfate-Induced Renal Dysfunction in Male Adult Zebrafish via Regulations of Mitochondrial Inflammatory and β-Carotene Oxygenase-2 Actions.

Muthuraman A, Sayem A, Meenakshisundaram S, Ali N, Ahmad S, Alasmari A Biomedicines. 2023; 11(10).

PMID: 37893028 PMC: 10603961. DOI: 10.3390/biomedicines11102654.


The Effects of Extracts on IgA Nephropathy: A Systematic Review and Meta-Analysis.

Adam G, Adam A, Robu S, Harabor V, Harabor A, Nechita A Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513901 PMC: 10385934. DOI: 10.3390/ph16070988.


Minnelide Markedly Reduces Proteinuria in Mice with Adriamycin Nephropathy by Protecting Against Podocyte Injury.

Ji B, Liu J, Ma Y, Yin Y, Xu H, Shen Q Appl Biochem Biotechnol. 2023; 195(12):7379-7396.

PMID: 37000351 PMC: 10754751. DOI: 10.1007/s12010-023-04333-z.